Pathogenetic therapy in patients with COVID-19
The new coronavirus infection (COVID-19) has become a truly global challenge for all of humanity, and, above all, for the healthcare system. Among its most important aspects that require careful analysis are the clinical and laboratory features of the course of the disease, which make it possible to...
Saved in:
| Main Authors: | V. A. Kapatsina, M. A. Vashukova, D. A. Gusev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2022-10-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/1394 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of dendritic cells in COVID-19 infection
by: Xuying Wang, et al.
Published: (2023-12-01) -
Ageing and dysregulated lung immune responses in fatal COVID-19
by: Natália de Souza Xavier Costa, et al.
Published: (2025-07-01) -
IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
by: Sophia Davidson, et al.
Published: (2016-08-01) -
STUDY OF CLINICAL AND PATHOGENETIC EFFECTS OF ANTI-VIRAL DRUG BASED ON FAVIPIRAVIR IN COMORBID PATIENTS WITH COVID-19 AT THE OUTPATIENT STAGE OF TREATMENT
by: L. A. Balykova, et al.
Published: (2021-12-01) -
Interplay Between Viral Shedding, Age, and Symptoms in Individual Infectivity of COVID-19 Breakthrough Infections in Households
by: Shuaibing Dong, et al.
Published: (2025-03-01)